The in vivo data from untreated and post-SAHA treated tumor biopsy samples showed that SAHA increased acetylation of hsp90 and alpha tubulin, and reduced expression of HDAC6 and hsp90, leading to depletion of hsp90 client proteins that promote cell survival. This evidence concerns the gene TUBA1B and neoplasm.